Global Sensory Organ Partnering Deals Directory 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Sensory Organ Partnering 2014-2019: Deal Trends, Players and Financials”
report has been added to ResearchAndMarkets.com’s
offering.

Global Sensory Organ Partnering 2014 to 2019 provides the full
collection of Sensory Organ disease deals signed between the world’s
pharmaceutical and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee
obtains a right or an option right to license a licensor’s product or
technology. More often these days these deals tend to be multi-component
including both a collaborative R&D and a commercialization of outcomes
element.

The report takes readers through the comprehensive Sensory Organ disease
deal trends, key players and top deal values allowing the understanding
of how, why and under what terms companies are currently entering
Sensory Organ deals.

The report presents financial deal terms values for Sensory Organ deals,
where available listing by overall headline values, upfront payments,
milestones and royalties enabling readers to analyse and benchmark the
value of current deals.

The initial chapters of this report provide an orientation of Sensory
Organ dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Sensory Organ dealmaking
since 2014 covering trends by year, deal type, stage of development,
technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline
value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Sensory Organ deals since
2014. Deals are listed by headline value. The chapter includes the top
25 most active Sensory Organ dealmakers, together with a full listing of
deals to which they are a party. Where the deal has an agreement
contract published at the SEC a link provides online access to the
contract.

Chapter 5 provides comprehensive access to Sensory Organ deals since
2014 where a deal contract is available, providing the user with direct
access to contracts as filed with the SEC regulatory authorities. Each
deal title links via Weblink to an online version of the deal record
contract document, providing easy access to each contract document on
demand.

Chapter 6 provides a comprehensive directory of all Sensory Organ
partnering deals by specific Sensory Organ target announced since 2014.
The chapter is organized by specific Sensory Organ therapeutic target.
Each deal title links via Weblink to an online version of the deal
record and where available, the contract document, providing easy access
to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of
all Sensory Organ partnering deals signed and announced since 2014. The
appendices are organized by company A-Z, stage of development at
signing, deal type (collaborative R&D, co-promotion, licensing etc) and
technology type. Each deal title links via Weblink to an online version
of the deal record and where available, the contract document, providing
easy access to each contract document on demand.

Report Scope

Global Sensory Organ Partnering 2014 to 2019 includes:

• Trends in Sensory Organ dealmaking in the biopharma industry since 2014
• Analysis of Sensory Organ deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Sensory Organ deal contract documents
• Comprehensive access to over 3500 Sensory Organ deal records
• The leading Sensory Organ deals by value since 2014
• Most active Sensory Organ dealmakers since 2014

Available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication

Key Topics Covered:

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Sensory Organ dealmaking

2.1. Introduction

2.2. Sensory Organ partnering over the years

2.3. Sensory Organ partnering by deal type

2.4. Sensory Organ partnering by industry sector

2.5. Sensory Organ partnering by stage of development

2.6. Sensory Organ partnering by technology type

2.7. Sensory Organ partnering by therapeutic indication

Chapter 3 – Financial deal terms for Sensory Organ partnering

3.1. Introduction

3.2. Disclosed financials terms for Sensory Organ partnering

3.3. Sensory Organ partnering headline values

3.4. Sensory Organ deal upfront payments

3.5. Sensory Organ deal milestone payments

3.6. Sensory Organ royalty rates

Chapter 4 – Leading Sensory Organ deals and dealmakers

4.1. Introduction

4.2. Most active in Sensory Organ partnering

4.3. List of most active dealmakers in Sensory Organ

4.4. Top Sensory Organ deals by value

Chapter 5 – Sensory Organ contract document directory

5.1. Introduction

5.2. Sensory Organ partnering deals where contract document available

Chapter 6 – Sensory Organ dealmaking by therapeutic target

6.1. Introduction

6.2. Deals by Sensory Organ therapeutic target

Appendices

Appendix 1 – Directory of Sensory Organ deals by company A-Z 2014 to 2019

Appendix 2 – Directory of Sensory Organ deals by deal type 2014 to 2019

Appendix 3 – Directory of Sensory Organ deals by stage of development
2014 to 2019

Appendix 4 – Directory of Sensory Organ deals by technology type 2014 to
2019

For more information about this report visit https://www.researchandmarkets.com/research/n353q6/global_sensory?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Pharmaceuticals